Anika to Participate in Upcoming Investor Conferences
August 25 2016 - 4:05PM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated
orthopedic medicines company specializing in therapeutics based on
its proprietary hyaluronic acid (“HA”) technology, today announced
that its Chief Financial Officer, Sylvia Cheung, will participate
in the following upcoming investor conferences:
- Barrington Research Fall Investment
Conference on Thursday, September 8, 2016. The conference consists
of 1:1 meetings, and it is being held at the Four Seasons hotel in
Chicago.
- Morgan Stanley Global Healthcare
Conference on Monday, September 12, 2016. Ms. Cheung is scheduled
to present at 5:25 pm ET. The conference is being held at the Grand
Hyatt hotel in New York City.
- Rodman & Renshaw 18th Annual Global
Investment Conference on Tuesday, September 13, 2016. Ms. Cheung is
scheduled to present at 2:35 pm ET. The conference is being held at
the Lotte New York Palace hotel in New York City.
Live audio webcasts of the Morgan Stanley and Rodman &
Renshaw presentations may be accessed via the “Investor Relations”
section of Anika’s website at www.anikatherapeutics.com. Audio
archives of the presentations also will be available on the website
shortly after the conclusion of the conferences.
About Anika Therapeutics, Inc.Anika Therapeutics, Inc.
(NASDAQ: ANIK) is a global, integrated orthopedic medicines company
based in Bedford, Mass. Anika is committed to improving the lives
of patients with degenerative orthopedic diseases and traumatic
conditions by providing clinically meaningful therapeutic pain
management solutions along the continuum of care, from palliative
care to regenerative medicine. The Company has over two decades of
expertise developing, manufacturing and commercializing more than
20 products, in markets across the globe, based on its proprietary
hyaluronic acid (HA) technology. Anika’s orthopedic medicine
portfolio is comprised of marketed (ORTHOVISC® and MONOVISC®) and
pipeline (CINGAL® and HYALOFAST® in the U.S.) products to alleviate
pain and restore joint function by replenishing depleted HA and
aiding cartilage repair and regeneration. For more information
about Anika, please visit www.anikatherapeutics.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160825005123/en/
For Investor Inquiries:Anika Therapeutics, Inc.Sylvia Cheung,
781-457-9000Chief Financial Officeror
For Media Inquiries:Pure Communications, Inc.Susan Heins,
864-286-9597
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024